期刊文献+

核转录因子κB在门静脉高压大鼠肺血管中的表达及意义 被引量:1

Expression of NF-κB in Pulmonary Vessels of Rats with Portal Hypertension and Its Implications
下载PDF
导出
摘要 目的:探讨核转录因子-κB(NF-κB)在门脉高压大鼠肺血管中的表达及意义。方法:建立门脉高压大鼠模型,将实验动物随机分为三组:实验模型组,银杏治疗组,对照组,动态观察其肺血管NF-κBp65的表达。结果:对照组平均光密度值0.2229±0.0008、实验组0.3007±0.0044、治疗组0.2866±0.0037。造模后第2周、3周、4周,实验组为:0.2739±0.0383、0.2982±0.0754、0.3202±0.0592;治疗组为:0.2625±0.0534、0.2890±0.0686、0.2918±0.0683。对三组结果进行两两非配对t检验,都具有显著性差异(P<0.01);相同时间段实验组与治疗组间亦具有显著性差异(P<0.01)。结论:门脉高压可促成肺血管组织NF-κBp65的高表达,并在门脉高压引起的血管病变中发挥重要作用;银杏注射液对NF-κBp65的高表达有抑制作用。 Objective: To investigate the expression of NF-κB in pulmonary vessels of rats with portal hypenension(PH) and its implications. Method: Rats were randomly allocated to three groups: ①Experimental group; ②Treatment group; ③Control group. Detected the expression of NF-κB by immunohistochemistry. Results: There are significant difference between each two groups (P〈0.01), even during the same period of time there are significant difference too( P〈 0.01 ). Conclusion: PH can cause over expression of NF-κB in pulmonary vessels of rats. NF-κB may play an important role in PH vasculopathy. Therapeutic treatment of Gingko injection can inhibne over-expression of NF-κB p65 induced by PH.
出处 《微循环学杂志》 2005年第3期22-23,F0004,F0005,F0008,共5页 Chinese Journal of Microcirculation
  • 相关文献

参考文献2

二级参考文献14

  • 1朱秀媛 王文杰 等.麝香的药理研究Ⅱ麝香及其有效成分的抗炎作用[J].药学学报,1988,23(6):406-406.
  • 2[1]Karin M, Ben-Neriah Y. Phosphorylation meets ubiquition: The control of NF-κB activity. Annu Rev Immunol, 2000,18 621~663.
  • 3[2]Morishita R, Sugimoto T, Aoki M, et al. In vivo transfection of cis element "decoy" against nuclear factor-κB binding site prevents myocardial infarction. Nature Medicine, 1997, 3 894~899.
  • 4[3]Gill JS, Zhu X, Moore MJ, et al. Effects of NFκB decoy oligonucleotides released from biodegradable polymer microparticles on a glioblastoma cell line. Biomaterials, 2002,23 2773~2781.
  • 5[4]Hirokazu U, Minoru H, Masashi K, et al. Inhibition of inducible NF-κB activity reduces chemoresistance to 5-fluorouracil in human stomach cancer cell line. Experimental Cell Research, 2003,289 27~35.
  • 6[5]Kupatt C, Wichels R, Deiis M, et al. Retroinfusion of NF-κB decoy oligonucleotide extends cardioprotein achieved by CD18 inhibition in a preclinical study of myocardial ischemia and retroinfusion in pigs. Gene Therapy, 2002,9 518~526.
  • 7[6]Yokoseki O, Suauki J, Kitabayashi H, et al. cis Element decoy against nuclear factor-κB attenuates development of experimental autoimmune myocarditis in rats. Circ Res, 2001,89 899~906.
  • 8[7]Tomita N, Morishita R, Lan HY, et al. In vivo administration of a nuclear transcription factor-κB decoy suppresses experimental crescentic glomerulonephritis. J Am Soc Nephrol, 2000, 11 1244~1252.
  • 9[8]Ingrid HC, Roland G, Hermann JG, et al. NFκB decoy oligodeoxynucleotides reduce monocyte infiltration in renal allografts. The FASEB Journal, 2000,14 815~821.
  • 10[9]Quan N, Ho E, La W, et al. Administration of NF-κB decoy inhibits pancreatic activation of NF-κB and prevents diabetogenesis by alloxan in mice. The FASEB Journal, 2001,15 1616~1618.

共引文献16

同被引文献24

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部